CSIO yields 0.67% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 5
Combined, CSIO + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CSIO + JNJ for your $10,000?
CSIO invests primarily in a concentrated portfolio of US and international infrastructure companies. Security selection is based on a value-oriented, bottom-up research process, evaluating firms on financial strength, management quality, industry positioning, and valuation metrics such as price/earnings, price/cash flow, dividend yield, and earnings growth. Eligible company exposure ranges from utilities, energy transport, communications networks, transportation systems, social infrastructure, and related suppliers, with up to 25% allocated to emerging markets. While CSIOs focus is common stocks, the fund may also hold preferred securities, hybrids, PIPEs, REIT-structured infrastructure assets, IPOs, and up to 20% in fixed-income securities. The fund does not target specific ESG outcomes but considers relevant ESG factors when assessing opportunities. Derivatives and currency hedging may be used mainly for risk management purposes.
Full CSIO Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.